Investigations of the transition from progenitor to terminal exhausted state of CD4+ T cells found down-regulation of naïve markers (TCF1, SLAMF6) on tumor-infiltrating CD4+ T cells compared to cells in the spleen [54], leading to ACT failure that could be rescued with checkpoint blockade (anti-PD-L1 treatment). Here, CD4 is linked to neoplasm.